Literature DB >> 28489293

The role of family history of depression and the menopausal transition in the development of major depression in midlife women: Study of women's health across the nation mental health study (SWAN MHS).

Alicia Colvin1, Gale A Richardson2, Jill M Cyranowski3, Ada Youk4, Joyce T Bromberger1,2.   

Abstract

BACKGROUND: This study evaluated whether family history of depression predicts major depression in midlife women above and beyond static risk factors (such as personal history of depression prior to midlife) and risks that may change dynamically across midlife (such as menopausal, psychosocial, and health profiles).
METHODS: Participants were 303 African American and Caucasian women (42-52 years at baseline) recruited into the Study of Women's Health across the Nation (SWAN) Mental Health Study (MHS) in Pittsburgh. Major depression was assessed annually with Structured Clinical Interviews for DSM-IV. Family mental health history was collected at the ninth or tenth annual follow-up. Random effects logistic regression was used to assess the relationship between family history of depression and midlife depression, controlling for baseline sociodemographic characteristics and time-varying risk factors.
RESULTS: Family history of depression was associated with midlife depression after adjusting for participant's history of major depression prior to midlife, trait anxiety and baseline age, and time-varying menopausal status, body mass index, very upsetting life events, and chronic difficulties (OR = 2.24, 95% CI = 1.17-4.29, P = .02). Higher odds of major depression were found when women were late perimenopausal or postmenopausal relative to when they were premenopausal or early perimenopausal (OR = 3.01, 95% CI = 1.76-5.15, P < .0001). However, menopausal status was only associated with major depression among women without a family history.
CONCLUSIONS: Family history of depression predicts major depression in midlife women independent of the menopausal transition and other time-varying covariates. Notably, the menopausal transition was associated with increased risk only among women without a family history of depression.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  depression; epidemiology; family; life events/stress; mood disorders

Mesh:

Year:  2017        PMID: 28489293      PMCID: PMC5585035          DOI: 10.1002/da.22651

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  75 in total

1.  "MENOPAUSAL SYMPTOMS" IN WOMEN OF VARIOUS AGES.

Authors:  B L NEUGARTEN; R J KRAINES
Journal:  Psychosom Med       Date:  1965 May-Jun       Impact factor: 4.312

2.  Obesity and depression: results from the longitudinal Northern Finland 1966 Birth Cohort Study.

Authors:  A Herva; J Laitinen; J Miettunen; J Veijola; J T Karvonen; K Läksy; M Joukamaa
Journal:  Int J Obes (Lond)       Date:  2006-03       Impact factor: 5.095

3.  The family history method using diagnostic criteria. Reliability and validity.

Authors:  N C Andreasen; J Endicott; R L Spitzer; G Winokur
Journal:  Arch Gen Psychiatry       Date:  1977-10

4.  Influences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women.

Authors:  K A Matthews; R R Wing; L H Kuller; E N Meilahn; S F Kelsey; E J Costello; A W Caggiula
Journal:  J Consult Clin Psychol       Date:  1990-06

5.  Early and late onset depression in young and middle aged adults: differential symptomatology, characteristics and risk factors?

Authors:  Nicole C M Korten; Hannie C Comijs; Femke Lamers; Brenda W J H Penninx
Journal:  J Affect Disord       Date:  2012-02-26       Impact factor: 4.839

6.  Early-life risk factors for late-onset depression.

Authors:  Joel R Sneed; Stephanie Kasen; Patricia Cohen
Journal:  Int J Geriatr Psychiatry       Date:  2007-07       Impact factor: 3.485

Review 7.  Obesity-depression associations in the population.

Authors:  Myles S Faith; Patty E Matz; Marie A Jorge
Journal:  J Psychosom Res       Date:  2002-10       Impact factor: 3.006

Review 8.  Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies.

Authors:  Floriana S Luppino; Leonore M de Wit; Paul F Bouvy; Theo Stijnen; Pim Cuijpers; Brenda W J H Penninx; Frans G Zitman
Journal:  Arch Gen Psychiatry       Date:  2010-03

9.  Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence.

Authors:  R C Kessler; K A McGonagle; M Swartz; D G Blazer; C B Nelson
Journal:  J Affect Disord       Date:  1993 Oct-Nov       Impact factor: 4.839

10.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

View more
  8 in total

1.  Peri- and postmenopause-diagnosis and interventions interdisciplinary S3 guideline of the association of the scientific medical societies in Germany (AWMF 015/062): short version.

Authors:  Olaf Ortmann; Maria J Beckermann; Elisabeth C Inwald; Thomas Strowitzki; Eberhard Windler; Clemens Tempfer
Journal:  Arch Gynecol Obstet       Date:  2020-07-13       Impact factor: 2.344

2.  Depressive Symptoms and Healthy Behavior Frequency in Polish Postmenopausal Women from Urban and Rural Areas.

Authors:  Mariusz Gujski; Dorota Raczkiewicz; Ewa Humeniuk; Beata Sarecka-Hujar; Artur Wdowiak; Iwona Bojar
Journal:  Int J Environ Res Public Health       Date:  2021-03-14       Impact factor: 3.390

3.  Decreased Medial Prefrontal Cortex Glutamate Levels in Perimenopausal Women.

Authors:  Sidney Yap; Jessica Luki; Christopher C Hanstock; Peter Seres; Tami Shandro; Sarah E C Hanstock; Alynna Lirette; Huaying Helen Zhao; Katherine J Aitchison; Jean-Michel Le Melledo
Journal:  Front Psychiatry       Date:  2021-12-13       Impact factor: 4.157

4.  Comparative safety and efficacy of tibolone and escitalopram in postmenopausal women.

Authors:  Rajnish Raj; Namita Sharma; Rohit Garg; Ekram Goyal
Journal:  Ind Psychiatry J       Date:  2021-10-22

5.  Biopsychosocial risk factors of depression during menopause transition in southeast China.

Authors:  Ketan Chu; Jing Shui; Linjuan Ma; Yizhou Huang; Fan Wu; Fang Wei; Xingjun Meng; Jie Luo; Fei Ruan; Jianhong Zhou
Journal:  BMC Womens Health       Date:  2022-07-05       Impact factor: 2.742

6.  Prevalence and predictors of depressive symptoms among married Egyptian women: a multicenter primary healthcare study.

Authors:  Doaa Mohamed Osman; Gellan K Ahmed; Manal Mukhtar Farghal; Ahmed K Ibrahim
Journal:  BMC Psychiatry       Date:  2022-09-10       Impact factor: 4.144

7.  Depressive symptoms and suicidality by menopausal stages among middle-aged Korean women.

Authors:  Se Young An; Yejin Kim; Ria Kwon; Ga-Young Lim; Hye Rin Choi; Sunju Namgoung; Sang Won Jeon; Yoosoo Chang; Seungho Ryu
Journal:  Epidemiol Psychiatr Sci       Date:  2022-08-26       Impact factor: 7.818

8.  Asparagus cochinchinensis extract ameliorates menopausal depression in ovariectomized rats under chronic unpredictable mild stress.

Authors:  Hye Ryeong Kim; Young-Ju Lee; Tae-Wan Kim; Ri-Na Lim; Dae Youn Hwang; Jeffrey J Moffat; Soonil Kim; Joung-Wook Seo; Minhan Ka
Journal:  BMC Complement Med Ther       Date:  2020-10-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.